FibroBiologics, Inc., 2026-10-13
A new SEC Form D private-offering notice from Houston, TX, a $1,200,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biotech developing fibroblast cell-based therapies for chronic diseases such as multiple sclerosis and degenerative disc disease.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- LUCIER PHARMACEUTICALS INC, 2026-10-13, $2M, Bryan, TX
- CURADEL SURGICAL INNOVATIONS, INC., 2026-10-13, $57.5M, Bonita Springs, FL
- Kraken Pop LLC, 2026-10-13, $45K, Galveston, TX
- EpiVario Inc., 2026-10-13, $500K, Philadelphia, PA
- Tesoro XP, Inc., 2026-10-13, $5M, Austin, TX
- Thetis Pharmaceuticals LLC, 2026-10-13, $1M, Deep River, CT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.